about
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes MellitusSwitch to Combined GLP1 Receptor Agonist Lixisenatide with Basal Insulin Glargine in Poorly Controlled T2DM Patients with Premixed Insulin Therapy: A Clinical Observation and Pilot Study in Nine Patients.Sex-specific differences in diabetes prevention: a systematic review and meta-analysis.Physical activity, depressed mood and pregnancy worries in European obese pregnant women: results from the DALI study.Association Study with 77 SNPs Confirms the Robust Role for the rs10830963/G of MTNR1B Variant and Identifies Two Novel Associations in Gestational Diabetes Mellitus DevelopmentBeliefs, Barriers, and Preferences of European Overweight Women to Adopt a Healthier Lifestyle in Pregnancy to Minimize Risk of Developing Gestational Diabetes Mellitus: An Explorative Study.Lipoprotein(a) is not related to markers of insulin resistance in pregnancy.Cardiometabolic Risk in Hyperlipidemic Men and Women.Associations of Body Mass Index (Maternal BMI) and Gestational Diabetes Mellitus with Neonatal and Maternal Pregnancy Outcomes in a Multicentre European Database (Diabetes and Pregnancy Vitamin D and Lifestyle Intervention for Gestational Diabetes MGestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review.Gestational diabetes mellitus and cardiovascular risk after pregnancy.Potential of a Sports Club-Based Exercise Program for Improving Physical Activity in Type 2 Diabetes Mellitus.Gliptin therapy reduces hepatic and myocardial fat in type 2 diabetic patients Gliptins and cardiometabolic risk.Sex and gender differences in therapy of type 2 diabetes.Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe.[Gender Obesity Report--Influence of obesity on Reproduction and Pregnancy].Is a motivational interviewing based lifestyle intervention for obese pregnant women across Europe implemented as planned? Process evaluation of the DALI study.Results From a European Multicenter Randomized Trial of Physical Activity and/or Healthy Eating to Reduce the Risk of Gestational Diabetes Mellitus: The DALI Lifestyle Pilot.Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial.Correlates of poor mental health in early pregnancy in obese European women.[Clinical practice recommendations for diabetes in pregnancy (Diabetes and Pregnancy Study Group of the Austrian Diabetes Association)].Evaluation of educational needs in patients with diabetes mellitus in respect of medication use in Austria.Effect of Physical Activity and/or Healthy Eating on GDM Risk: The DALI Lifestyle Study.Perspectives on gender-specific medicine, course and learning style preferences in medical education: a study among students at the Medical University of Vienna.Cost-effectiveness of healthy eating and/or physical activity promotion in pregnant women at increased risk of gestational diabetes mellitus: economic evaluation alongside the DALI study, a European multicenter randomized controlled trial.Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes.IADPSG and WHO 2013 Gestational Diabetes Mellitus Criteria Identify Obese Women With Marked Insulin Resistance in Early Pregnancy.Sex and Gender Differences in Prevention of Type 2 Diabetes.Management of Pregnant Women after Bariatric Surgery.The wave of sweetness and obesity continuesGestationsdiabetes (GDM)The rs10830963 Variant in Interaction with Pre-Pregnancy BMI is a Pharmacogenetic Marker for the Initiation of Antenatal Insulin Therapy in Gestational Diabetes MellitusMediators of Lifestyle Behaviour Changes in Obese Pregnant Women. Secondary Analyses from the DALI Lifestyle Randomised Controlled TrialRe: Vitamin D and gestational diabetes mellitus: a systematic review based on data free of Hawthorne effectRisk factors for hyperglycemia in pregnancy in the DALI study differ by period of pregnancy and OGTT time pointNeedle beats pill in gestational diabetes mellitusMann oder Frau: Ist das bei Diabetes relevant?Cord serum dipeptidyl-peptidase 4 activity in gestational diabetesA Sex-Specific Analysis of the Predictive Value of Troponin I and T in Patients With and Without Diabetes Mellitus After Successful Coronary InterventionA reduction in sedentary behaviour in obese women during pregnancy reduces neonatal adiposity: the DALI randomised controlled trial
P50
Q28395801-111CC217-8568-4610-A8F0-3DB7ABA72A95Q33732588-A4696280-2051-4208-842A-7B8FFEAE0F32Q35480518-4105B68D-D001-424D-A8AB-71F34CB719E9Q35728339-DD03219B-DB95-4496-BF7A-D8FD8A72447EQ36245625-92828DFB-FDC0-4916-B29A-5E4ADEA8E085Q36537254-DB193699-075C-411A-B431-AA468D2AB3F3Q37362217-4DAD9A4A-E84D-42B8-804C-186C2FAD093DQ37427570-512F0E3B-085D-4B67-8B39-68264C13CE6FQ37556335-C7CBC2FC-9CDA-4B64-994B-16DE956625EEQ37965823-A1764255-C01E-4DA6-B8EA-017EB467E1E5Q38170410-77D1D24E-7381-409A-B580-F3B8F2A4CF60Q38392335-52DA6FD9-5FB3-44A4-A51C-4BC836A7036FQ38620945-28825D98-359F-497F-8B2F-91F8DA3A047FQ38639226-20FD1691-DC08-4062-AD9C-A74A4FA63336Q38658400-B7BC9F5A-A8E0-441A-9185-FF9BC311FBEFQ41064810-B18AC41B-BFB7-47DF-B43C-0023B7AC130DQ41523194-BD387A6A-663B-46E2-98B2-F8E3A7EF8865Q41641098-19A9D2CB-4374-4435-ABEF-497212F7B088Q44997646-0EC92DA7-9D61-4B1A-B190-CFC2125E9DDAQ46301061-DC6FD35D-3835-4DA3-81F7-F86F19DB60DBQ46308805-5898474A-0AF6-46E0-9C08-3EBC50D7755CQ47864097-C788C9DE-CBE7-4B06-80C4-253C8A3DA3BDQ48725340-7B3CBF10-683D-473D-871E-F347FF6F8CA9Q51052674-F15EE82D-C8F4-4D12-AC35-6B20E88B3122Q51245313-74F33F77-1BB0-41F3-939D-AD85E46FE6B2Q51355578-1C121EA6-2406-41B4-AF73-52B1D5E63207Q53784842-178640AA-3940-4060-879F-F93F7E2A18A9Q54974312-3464E6D2-2FA1-4615-A10F-68E8318ECDA7Q55431981-0A8C7B94-8B22-4581-BBE0-000C1D7F32EAQ58097812-D43E9483-4046-4871-A8C9-1D677EC2E35EQ59341261-6B6AAB84-1DF4-4C65-BFF4-4AE7E7160AFDQ60949444-678FDE8A-970C-4980-8C44-E1BBA3D56A8FQ61964197-494D5564-DAEE-4B89-A848-351B69873D0DQ61964198-E145DB7A-FB47-4A30-A13E-865DFFD059DBQ61964209-EEE4557C-98F2-4C6B-A701-BB7B5628227AQ62774030-4966C4FF-6C95-42F5-8447-B8E0C6EE7AAEQ62774157-19EE2A72-CFE3-4562-8632-AEBEED264D2EQ62774484-414EBE37-5D69-4150-8296-4FB4D7104650Q64076629-B365FF68-F989-4A8B-8150-EB58F09CEB73Q64245213-E4B93375-73CA-42A1-B406-D239B6CE3854
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jürgen Harreiter
@ast
Jürgen Harreiter
@en
Jürgen Harreiter
@es
Jürgen Harreiter
@nl
type
label
Jürgen Harreiter
@ast
Jürgen Harreiter
@en
Jürgen Harreiter
@es
Jürgen Harreiter
@nl
prefLabel
Jürgen Harreiter
@ast
Jürgen Harreiter
@en
Jürgen Harreiter
@es
Jürgen Harreiter
@nl
P106
P31
P496
0000-0003-2508-9403